600422 Share Price Performance
CN¥0
-17.55 (-100.00%)
Price CN¥0
Share Pricen/a
KPC Pharmaceuticals,Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
600422 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
KPC Pharmaceuticals,Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 25, 2026
- 0.46
- 38.21%
- 5.32%
- 23.1%
About 600422
- Founded
- 1951
- Employees
- 5275
- CEO
- WebsiteView website
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections and others. The company’s brands such as Luotai, Tianxuanqing, Artemedine, Artem and Arco. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People’s Republic of China.
